|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||13.30 - 13.30|
|52 Week Range||13.30 - 13.30|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The San Diego company reported a 9% increase in adjusted revenue to $651.1 million but lagged Wall Street's expectations of $667 million. "We had a solid quarter with top-line growth and gross margin expansion, as well as continued fiscal discipline to drive leverage and improved operating profit," said Mick Farrell, ResMed's CEO. Through the first half of the company's fiscal year, ResMed has posted an increase of 11% on adjusted revenue while earnings have gained 9%.
These are the companies making headlines in the middle of Friday trading:Intel INTC , AMD AMD – Intel fell 5.5 percent after the chipmaker said it expects revenue to be nearly flat compared to last year.
Stone futures rose but pared gains on news that Trump adviser Roger Stone had been arrested. Intel fell on guidance. Starbucks rose on strong earnings.
ResMed stock crashed Thursday after the medical technology firm missed quarterly sales projections by $16 million. ResMed stock closed up a fraction.
On a per-share basis, the San Diego-based company said it had net income of 86 cents. Earnings, adjusted for amortization costs and costs related to mergers and acquisitions, came to $1 per share. The ...